These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37028882)

  • 1. Absolute pharmacokinetics of heparin in primates.
    Song Y; Kouta A; Cera LM; Xia K; Zhang F; Kraemer R; Fareed J; Linhardt RJ; Jeske W
    Carbohydr Polym; 2023 Jul; 311():120779. PubMed ID: 37028882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of 3-O-sulfo group-containing heparin tetrasaccharides in heparin by liquid chromatography-mass spectrometry.
    Li G; Yang B; Li L; Zhang F; Xue C; Linhardt RJ
    Anal Biochem; 2014 Jun; 455():3-9. PubMed ID: 24680753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemometric analysis of porcine, bovine and ovine heparins.
    Ouyang Y; Han X; Yu Y; Chen J; Fu L; Zhang F; Linhardt RJ; Fareed J; Hoppensteadt D; Jeske W; Kouta A; Zhang Z; Xia K
    J Pharm Biomed Anal; 2019 Feb; 164():345-352. PubMed ID: 30428408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quantitative mass spectrometry method to differentiate bovine and ovine heparins from pharmaceutical porcine heparin.
    Zhang B; Shi D; Li M; Shi F; Chi L
    Carbohydr Polym; 2023 Feb; 301(Pt A):120303. PubMed ID: 36436866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin and anticoagulation.
    Onishi A; St Ange K; Dordick JS; Linhardt RJ
    Front Biosci (Landmark Ed); 2016 Jun; 21(7):1372-92. PubMed ID: 27100512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The C-terminal fragment of axon guidance molecule Slit3 binds heparin and neutralizes heparin's anticoagulant activity.
    Condac E; Strachan H; Gutierrez-Sanchez G; Brainard B; Giese C; Heiss C; Johnson D; Azadi P; Bergmann C; Orlando R; Esmon CT; Harenberg J; Moremen K; Wang L
    Glycobiology; 2012 Sep; 22(9):1183-92. PubMed ID: 22641771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Pharmacological Profiles of Various Bovine, Ovine, and Porcine Heparins.
    Kouta A; Jeske W; Hoppensteadt D; Iqbal O; Yao Y; Fareed J
    Clin Appl Thromb Hemost; 2019; 25():1076029619889406. PubMed ID: 31793333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Filter-entrapment enrichment pull-down assay for glycosaminoglycan structural characterization and protein interaction.
    Yu Y; Zhang F; Renois-Predelus G; Amster IJ; Linhardt RJ
    Carbohydr Polym; 2020 Oct; 245():116623. PubMed ID: 32718661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel method for measurement of heparin anticoagulant activity using SPR.
    Zhao J; Liu X; Malhotra A; Li Q; Zhang F; Linhardt RJ
    Anal Biochem; 2017 Jun; 526():39-42. PubMed ID: 28322799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin: An old drug for new clinical applications.
    Wang P; Chi L; Zhang Z; Zhao H; Zhang F; Linhardt RJ
    Carbohydr Polym; 2022 Nov; 295():119818. PubMed ID: 35989029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of Low Molecular Weight Heparin from a Remodeled Bovine Intestinal Heparin.
    Baytas SN; Varghese SS; Jin W; Yu Y; He P; Douaisi M; Zhang F; Brodfuehrer P; Xia K; Dordick JS; Linhardt RJ
    J Med Chem; 2021 Feb; 64(4):2242-2253. PubMed ID: 33586962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Pharmacokinetic Profile of 3 Batches of Ovine Low-Molecular-Weight Heparin and 1 Batch of Branded Enoxaparin.
    Jeske W; Kouta A; Duff R; Rangnekar V; Niverthi M; Hoppensteadt D; Fareed J; Yao Y
    Clin Appl Thromb Hemost; 2018 Dec; 24(9_suppl):150S-156S. PubMed ID: 30198315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Analysis of Heparin-Derived 3-O-Sulfated Tetrasaccharides: Antithrombin Binding Site Variants.
    Chen Y; Lin L; Agyekum I; Zhang X; St Ange K; Yu Y; Zhang F; Liu J; Amster IJ; Linhardt RJ
    J Pharm Sci; 2017 Apr; 106(4):973-981. PubMed ID: 28007564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal muscle myosin and cardiac myosin attenuate heparin's antithrombin-dependent anticoagulant activity.
    Morla S; Deguchi H; Griffin JH
    J Thromb Haemost; 2021 Feb; 19(2):470-477. PubMed ID: 33176060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinatorial one-pot chemoenzymatic synthesis of heparin.
    Bhaskar U; Li G; Fu L; Onishi A; Suflita M; Dordick JS; Linhardt RJ
    Carbohydr Polym; 2015 May; 122():399-407. PubMed ID: 25817684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With Enoxaparin.
    Chen J; Yu Y; Fareed J; Hoppensteadt D; Jeske W; Kouta A; Jin C; Jin Y; Yao Y; Xia K; Zhang F; Chen S; Ye X; Linhardt RJ
    Clin Appl Thromb Hemost; 2019; 25():1076029619840701. PubMed ID: 30987427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.
    Tovar AM; Capillé NV; Santos GR; Vairo BC; Oliveira SN; Fonseca RJ; Mourão PA
    Thromb Haemost; 2012 May; 107(5):903-15. PubMed ID: 22437650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic oligosaccharides as heparin-mimetics displaying anticoagulant properties.
    Avci FY; Karst NA; Linhardt RJ
    Curr Pharm Des; 2003; 9(28):2323-35. PubMed ID: 14529394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical and pharmacological aspects of neutralization of heparins from different animal sources by protamine.
    Glauser BF; Santos GRC; Silva JD; Tovar AMF; Pereira MS; Vilanova E; Mourão PAS
    J Thromb Haemost; 2018 Sep; 16(9):1789-1799. PubMed ID: 29968421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assays and reference materials for current and future applications of heparins.
    Mulloy B; Hogwood J; Gray E
    Biologicals; 2010 Jul; 38(4):459-66. PubMed ID: 20338781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.